 South Africa Health Products Regulatory Authority SAHPRA has approved Chembio Diagnostics Incs NASDAQ:CEMI DPP SARS-CoV-2 Antigen test for use at the point of care. The DPP SARS-CoV-2 Antigen test has been designed to detect SARS-CoV-2 antigens in only 20 minutes. 